UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

The Lancet (British edition), 2009, Vol.374 (9688), p.459-466

2009

Volltextzugriff (PDF)

Intermittent photic stimulation triggering a temporal lobe seizure in a patient with schizencephaly and pachygyria

Epilepsy & behavior reports, 2021-01, Vol.15, p.100395, Article 100395

2021

Volltextzugriff (PDF)

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients

Scandinavian journal of rheumatology, 2012-03, Vol.41 (2), p.116-119

2012

Volltextzugriff (PDF)

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

Scandinavian journal of rheumatology, 2010-11, Vol.39 (6), p.447-453

2010

Volltextzugriff (PDF)

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

Annals of the rheumatic diseases, 2003-06, Vol.62 (6), p.526-529

2003

Volltextzugriff (PDF)

Inhibition of Neutrophil‐Dependent Cytotoxicity for Human Endothelial Cells by ACE Inhibitors

Scandinavian journal of immunology, 2014-11, Vol.80 (5), p.339-345

2014

Volltextzugriff (PDF)

Do peer educators make a difference? An evaluation of a youth-led HIV prevention model in Zambian Schools

Health education research, 2012-04, Vol.27 (2), p.237-247

2012

Volltextzugriff (PDF)

Hydrogels for lung tissue engineering: Biomechanical properties of thin collagen–elastin constructs

Journal of the mechanical behavior of biomedical materials, 2014-10, Vol.38, p.251-259

2014

Volltextzugriff (PDF)

OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A82-A82

2013

Volltextzugriff (PDF)

Anti‐tumour necrosis factor (TNF)‐α therapy (etanercept) down‐regulates serum matrix metalloproteinase (MMP)‐3 and MMP‐1 in rheumatoid arthritis

British journal of rheumatology, 2002-05, Vol.41 (5), p.484-489

2002

Volltextzugriff (PDF)

Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital

Scandinavian journal of rheumatology, 2005, Vol.34 (5), p.353-358

2005

Volltextzugriff (PDF)

OP0155 Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality of life results of the randomised, controlled swefot trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.106-106

2013

Volltextzugriff (PDF)

No additional steroid-sparing effect of cyclosporine A in giant cell arteritis

Scandinavian journal of rheumatology, 2006, Vol.35 (4), p.327-329

2006

Volltextzugriff (PDF)

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

The Lancet (British edition), 2012, Vol.379 (9827), p.1712-1720

2012

Volltextzugriff (PDF)

Cytokine-induced neutrophil-mediated injury of human endothelial cells

The Journal of immunology (1950), 1997-07, Vol.159 (2), p.912-918

1997

Volltextzugriff (PDF)

Structural characterization of a prolyl aminodipeptidase (PepX) from Lactobacillus helveticus

Acta crystallographica. Section F, Structural biology communications, 2019-10, Vol.75 (10), p.625-633

2019

Volltextzugriff (PDF)

Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.469-475

2011

Volltextzugriff (PDF)

A comparison of four approaches for measuring clinician time use

Health policy and planning, 1999-12, Vol.14 (4), p.374-381

1999

Volltextzugriff (PDF)

Probing the Active Site of Human Manganese Superoxide Dismutase: The Role of Glutamine 143

Biochemistry (Easton), 1998-04, Vol.37 (14), p.4731-4739

1998

Volltextzugriff (PDF)

Pentraxin-3 and soluble tumor necrosis factor-like weak inducer of apoptosis (s-Tweak) in anti-neutrophil antibody associated vasculitis (AAV)

La Presse médicale (1983), 2013-04, Vol.42 (4), p.758-758

2013

Volltextzugriff (PDF)

Comparison of Soluble ICAM-1, VCAM-1 and E-Selectin Levels in Patients with Episodic Cluster Headache and Giant Cell Arteritis

Cephalalgia, 2008-02, Vol.28 (2), p.157-163

2008

Volltextzugriff (PDF)

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.230-233

2010

Volltextzugriff (PDF)

Interleukin-1β influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis

Scandinavian journal of rheumatology, 2006-05, Vol.35 (3), p.182-188

2006

Volltextzugriff (PDF)

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1094-1101

2015

Volltextzugriff (PDF)

Biochemical Characterization and Crystal Structure Determination of Human Heart Short Chain l-3-Hydroxyacyl-CoA Dehydrogenase Provide Insights into Catalytic Mechanism

Biochemistry (Easton), 1999-05, Vol.38 (18), p.5786-5798

1999

Volltextzugriff (PDF)

1 – 25 von 637

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(512)
Mit Volltextzugriff
(518)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(281)
EZB Electronic Journals Library
(245)
IngentaConnect Journals
(234)
Journals@Ovid
(225)
Elsevier ScienceDirect Journals Complete
(134)
Publisher website
(112)
Wiley Online Library Journals
(94)
Wiley Online Library
(78)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(76)
IngentaConnect Journals
(75)
Taylor & Francis Online
(41)
Taylor & Francis Journals
(41)
JSTOR
(40)
Taylor & Francis Journals
(40)
Oxford Journals
(32)
BMJ
(27)
Springer Nature
(25)
Oxford Journals 2020 Medicine
(22)
Ebook Central Perpetual and DDA
(20)
SAGE Journals
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Intermittent photic stimulation triggering a temporal lobe seizure in a patient with schizencephaly and pachygyria

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

Inhibition of Neutrophil‐Dependent Cytotoxicity for Human Endothelial Cells by ACE Inhibitors

Do peer educators make a difference? An evaluation of a youth-led HIV prevention model in Zambian Schools

Hydrogels for lung tissue engineering: Biomechanical properties of thin collagen–elastin constructs

OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial

Anti‐tumour necrosis factor (TNF)‐α therapy (etanercept) down‐regulates serum matrix metalloproteinase (MMP)‐3 and MMP‐1 in rheumatoid arthritis

Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital

OP0155 Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality of life results of the randomised, controlled swefot trial

No additional steroid-sparing effect of cyclosporine A in giant cell arteritis

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

Cytokine-induced neutrophil-mediated injury of human endothelial cells

Structural characterization of a prolyl aminodipeptidase (PepX) from Lactobacillus helveticus

Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

A comparison of four approaches for measuring clinician time use

Probing the Active Site of Human Manganese Superoxide Dismutase: The Role of Glutamine 143

Pentraxin-3 and soluble tumor necrosis factor-like weak inducer of apoptosis (s-Tweak) in anti-neutrophil antibody associated vasculitis (AAV)

Comparison of Soluble ICAM-1, VCAM-1 and E-Selectin Levels in Patients with Episodic Cluster Headache and Giant Cell Arteritis

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage

Interleukin-1β influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

Biochemical Characterization and Crystal Structure Determination of Human Heart Short Chain l-3-Hydroxyacyl-CoA Dehydrogenase Provide Insights into Catalytic Mechanism

Suchergebnisse filtern